Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Defining antimicrobial resistance in cystic fibrosis

Publikation: Bidrag til tidsskriftReviewForskningpeer review

DOI

  1. Markers of bone turnover are reduced in patients with CF related diabetes; the role of glucose

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Seasonal fluctuation of lung function in cystic fibrosis: A national register-based study in two northern European populations

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Antibody response against Mycobacterium avium complex in cystic fibrosis patients measured by a novel IgG ELISA test

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. The choice of lung function reference equation affects clinical trial eligibility: Results from a cystic fibrosis cohort

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. IgG avidity to Pseudomonas aeruginosa over the course of chronic lung biofilm infection in cystic fibrosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Privatisation rescues function following loss of cooperation

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Treatment of candidemia in a nationwide setting: increased survival with primary echinocandin treatment

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Human genetic variation in GLS2 is associated with development of complicated Staphylococcus aureus bacteremia

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. The accessibility of topical treatment in the paranasal sinuses on operated cystic fibrosis patients assessed by scintigraphy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Helle Krogh Johansen (Medlem af forfattergruppering)
  • Antimicrobial Resistance in Cystic Fibrosis International Working Group
Vis graf over relationer

Antimicrobial resistance (AMR) can present significant challenges in the treatment of cystic fibrosis (CF) lung infections. In CF and other chronic diseases, AMR has a different profile and clinical consequences compared to acute infections and this requires different diagnostic and treatment approaches. This review defines AMR, explains how it occurs, describes the methods used to measure AMR as well as their limitations, and concludes with future directions for research and development in the area of AMR in CF.

OriginalsprogEngelsk
TidsskriftJournal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Vol/bind17
Udgave nummer6
Sider (fra-til)696-704
Antal sider9
ISSN1569-1993
DOI
StatusUdgivet - nov. 2018

ID: 56201233